Template:ACLS Narrow Irregular Tachycardia: Difference between revisions
| Line 4: | Line 4: | ||
**If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD) | **If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD) | ||
*Sinus Tachycardia with frequent PACs | *Sinus Tachycardia with frequent PACs | ||
**Treat underlying cause | |||
*[[A fib]] / A Flutter with variable conduction (see also [[Atrial Fibrillation with RVR]]) | *[[A fib]] / A Flutter with variable conduction (see also [[Atrial Fibrillation with RVR]]) | ||
**Check if patient has taken usual rate-control meds | |||
***If missed dose, may provide dose of home medication and observe for resolution | |||
**Determine whether patient is better candidate for rate control or rhythm control <ref>Frankel, G. et al. (2013) Rate versus rhythm control in atrial fibrillation. Canadian Family Physician 59(2), 161 - 168</ref> | |||
***Rate control preferred with: | |||
****Persistent A fib | |||
****Less symptomatic patients | |||
****Age 65 or older | |||
****Hypertension | |||
****No heart failure | |||
****Previous failure to cardiovert | |||
****Patient preference | |||
***Rhythm control preferred with: | |||
****Paroxismal or new A fib | |||
****More symptomatic patients | |||
****Age < 65 years | |||
****Heart failure clearly exacerbated by A fib | |||
****No history of rhythm control failure | |||
****Patient preference | |||
**Rate control with: | **Rate control with: | ||
***[[Diltiazem]] | ***[[Diltiazem]] | ||
***[[Metoprolol]] | ***[[Metoprolol]] | ||
***[[Amiodarone]] (good in setting of hypotension, CHF) | ***[[Amiodarone]] (good in setting of hypotension, CHF) | ||
***[[Digoxin]] (good in setting of CHF) | ***[[Digoxin]] (good in setting of CHF) | ||
**Synchronized [[Cardioversion]] (120-200 J) | **Rhythm conversion with: | ||
***Synchronized [[Cardioversion]] (120-200 J) | |||
****Best performed on patients with new onset A fib or patients fully therapeutically anti-coagulated for > 3 weeks | |||
***Procainamide [[Ottawa Aggressive ED Cardioversion Protocol]] | |||
Revision as of 21:08, 11 March 2019
Narrow Irregular Tachycardia
- Multi-focal atrial tachycardia (MAT)
- Treat underlying cause (hypokalemia, hypomagnesemia)
- If not symptomatic and rate < 110/120 bpm, may not require treatment (e.g., patient with MAT secondary to COPD)
- Sinus Tachycardia with frequent PACs
- Treat underlying cause
- A fib / A Flutter with variable conduction (see also Atrial Fibrillation with RVR)
- Check if patient has taken usual rate-control meds
- If missed dose, may provide dose of home medication and observe for resolution
- Determine whether patient is better candidate for rate control or rhythm control [1]
- Rate control preferred with:
- Persistent A fib
- Less symptomatic patients
- Age 65 or older
- Hypertension
- No heart failure
- Previous failure to cardiovert
- Patient preference
- Rhythm control preferred with:
- Paroxismal or new A fib
- More symptomatic patients
- Age < 65 years
- Heart failure clearly exacerbated by A fib
- No history of rhythm control failure
- Patient preference
- Rate control preferred with:
- Rate control with:
- Diltiazem
- Metoprolol
- Amiodarone (good in setting of hypotension, CHF)
- Digoxin (good in setting of CHF)
- Rhythm conversion with:
- Synchronized Cardioversion (120-200 J)
- Best performed on patients with new onset A fib or patients fully therapeutically anti-coagulated for > 3 weeks
- Procainamide Ottawa Aggressive ED Cardioversion Protocol
- Synchronized Cardioversion (120-200 J)
- Check if patient has taken usual rate-control meds
- ↑ Frankel, G. et al. (2013) Rate versus rhythm control in atrial fibrillation. Canadian Family Physician 59(2), 161 - 168
